Showing results (2751-2760 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|August 12, 2008
Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: a preliminary monocentric studyNicolas André, Angelique Rome, Carole Coze, et al.
Clinical Therapeutics|August 12, 2008
Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorderFrank D Gianfrancesco, Martha Sajatovic, Krithika Rajagopalan, et al.
Clinical Therapeutics|August 22, 2009
Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment periodHans Georg Kress, Anna Orońska, Zbigniew Kaczmarek, et al.
Clinical Therapeutics|August 22, 2009
Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studiesStephen Daniels, Jeffery Robbins, Christine R West, et al.
Clinical Therapeutics|August 22, 2009
One-year assessment of joint procurement of pharmaceuticals in the public health sector in JordanIbrahim Al-Abbadi, Abdelraouf Qawwas, Mahmoud Jaafreh, et al.
Clinical Therapeutics|August 22, 2009
Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient settingNancy M Yoon, Melissa K Cavaghan, Rocco L Brunelle, et al.
Clinical Therapeutics|August 22, 2009
Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in ThailandSuda Vannaprasaht, Susothorn Angsuthum, Yingyos Avihingsanon, et al.
Clinical Therapeutics|August 22, 2009
Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysisAhmed H Abdelhafiz, Min P Myint, John A Tayek, et al.
Clinical Therapeutics|August 25, 2009
A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophreniaJoshua T Kantrowitz, Leslie Citrome, Daniel C Javitt
Clinical Therapeutics|August 25, 2009
Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysisLiberty Fajutrao, Björn Paulsson, Sherry Liu, et al.
Pageof 680